As the final sessions of the 2023 congress of the American Society of Clinical Oncology (ASCO) draw to a close, attendees will reflect on a number of significan 6 June 2023
US biotech major Gilead Sciences’ recent investments into oncology—including its $11.9 billion acquisition of Kite Pharma in 2017—have made the company one of t 6 June 2023
Along with the big pharma players showing off the potential of their cancer drugs at the 2023 Annual Meeting of the American Society of Clinical Oncology (ASCO) 5 June 2023
Gilead Sciences subsidiary Kite prides itself on being a leader in the development of cell therapies, a claim backed by its pioneering work with Yescarta (axica 5 June 2023
Data presented at the American Society of Clinical Oncology (ASCO) reinforce enthusiasm for a new approach being developed by companies including Elevation Onco 5 June 2023
Both AstraZeneca and Merck & Co have presented data at the 2023 Annual Meeting of the American Society of Clinical Oncology (ASCO) that reflects the ability of 5 June 2023
In an oral presentation at the annual meeting of the American Society of Clinical Oncology (ASCO), Eli Lilly (NYSE: LLY) has revealed new data for its CD4 and C 5 June 2023
Building on the extraordinary success of its platform in producing an effective coronavirus vaccine, German mRNA specialist BioNTech is making inroads on a proj 2 June 2023
As the crowds descend on Chicago for the annual meeting of the American Society of Clinical Oncology (ASCO), The Pharma Letter interviews Eisai chief medical of 1 June 2023
This year’s meeting of the American Society of Clinical Oncology (ASCO) kicks off on Friday, with the highly anticipated plenary session taking place on Sunday. 31 May 2023
In the runup to this year’s meeting of the American Society of Clinical Oncology (ASCO), drugmakers around the world are lifting the curtain on the data they pl 31 May 2023
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.